CON: Patients with recurrent ovarian carcinoma should not be treated with antiangiogenic agents in combination with chemotherapy Journal Article
| Author: | Sabbatini, P. |
| Article Title: | CON: Patients with recurrent ovarian carcinoma should not be treated with antiangiogenic agents in combination with chemotherapy |
| Keywords: | cancer survival; overall survival; review; bevacizumab; doxorubicin; cancer combination chemotherapy; drug safety; hypertension; paclitaxel; recurrent cancer; carboplatin; progression free survival; quality of life; ovary cancer; heart infarction; ovary carcinoma; transient ischemic attack; unstable angina pectoris; single drug dose |
| Journal Title: | Clinical Ovarian Cancer |
| Volume: | 4 |
| Issue: | 2 |
| ISSN: | 1941-4390 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2011-12-01 |
| Start Page: | 74 |
| End Page: | 76 |
| Language: | English |
| DOI: | 10.1016/j.cloc.2012.02.009 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 May 2012" - "Source: Scopus" |
